Cost-Effectiveness Analysis of 12 Cervical Cancer Screenings

JAMA Internal Medicine

EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, MAY 13, 2019

Media advisory: To contact corresponding author George F. Sawaya, M.D., email Elizabeth Fernandez at elizabeth.fernandez@ucsf.edu. The full study, commentary and author interview are linked to this news release.

Embed this link to provide your readers free access to the full-text article: This link will be live at the embargo time https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2732691?guestAccessKey=269f58b8-5962-4c16-abe1-fabbd1f76d77&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=051319

 

Bottom Line: This cost-effectiveness analysis incorporates women’s preferences and estimates quality of life and economic outcomes for 12 cervical cancer screening strategies.

Authors: George F. Sawaya, M.D., of the University of California, San Francisco, and coauthors

 

(doi:10.1001/jamainternmed.2019.0299)

Editor’s Note: The articles conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email mediarelations@jamanetwork.org.